| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
CAI
Caris Life Sciences, Inc.
|
Oct 27, 2026 | BUY |
Strong Buy
-9.5% avg upside
21 analysts
|
$38.00
10.69% Upside
|
-32.0% | Β· |
|
GH
Guardant Health
|
Oct 27, 2026 | BUY |
Strong Buy
-3.1% avg upside
33 analysts
|
$210.00
17.51% Upside
|
-14.8% | Β· |
|
NTRA
Natera
|
Oct 27, 2026 | BUY |
Strong Buy
-13.3% avg upside
28 analysts
|
$430.00
3.81% Upside
|
-22.3% | Β· |
|
CDNA
CareDx
|
Oct 27, 2026 | BUY |
Strong Buy
-41.0% avg upside
18 analysts
|
$81.00
7.38% Downside
|
+10.4% | Β· |
|
IMDX
Insight Molecular Diagnostics
|
Oct 20, 2026 | HOLD |
Buy
+79.9% avg upside
10 analysts
|
β | -17.8% | Β· |
|
MDXH
MDxHealth
|
Oct 19, 2026 | HOLD |
Buy
+3860.3% avg upside
9 analysts
|
β | -33.3% | Β· |
|
PSNL
Personalis
|
Oct 06, 2026 | HOLD |
Buy
-6.1% avg upside
11 analysts
|
β | -2.0% | Β· |
|
NEO
NeoGenomics
|
Oct 06, 2026 | BUY |
Strong Buy
+19.1% avg upside
19 analysts
|
$28.00
61.18% Upside
|
-3.0% | Β· |
|
ADPT
Adaptive Biotechnologies
|
Sep 22, 2026 | BUY |
Strong Buy
+1.9% avg upside
17 analysts
|
$34.00
27.58% Upside
|
+3.5% | Β· |
|
DNA
Ginkgo Bioworks Holdings
|
Sep 04, 2026 | SELL |
Strong Sell
-32.3% avg upside
6 analysts
|
$5.00
55.48% Downside
|
-47.5% | Β· |
|
MXCT
MaxCyte
|
Aug 24, 2026 | HOLD |
Strong Buy
+151.6% avg upside
5 analysts
|
β | -14.4% | Β· |
|
TEM
Tempus AI, Inc. Class A
|
Aug 20, 2026 | BUY |
Buy
-0.3% avg upside
25 analysts
|
$80.00
10.80% Upside
|
+7.4% | Β· |
|
LUCD
Lucid Diagnostics
|
Aug 17, 2026 | BUY |
Strong Buy
+1104.3% avg upside
8 analysts
|
$2.50
517.63% Upside
|
-57.4% | Β· |
|
FRNM
Freenome Inc
|
Aug 17, 2026 | BUY |
Strong Buy
+44.3% avg upside
4 analysts
|
$17.00
36.31% Upside
|
-19.4% | Β· |
|
CERS
Cerus
|
Aug 14, 2026 | BUY |
Strong Buy
+135.7% avg upside
10 analysts
|
$4.00
75.51% Upside
|
-34.6% | Β· |
|
TKNO
Alpha Teknova
|
Aug 11, 2026 | BUY |
Strong Buy
+74.1% avg upside
8 analysts
|
$8.00
8.69% Upside
|
+24.4% | Β· |
|
BLLN
BillionToOne, Inc. Class A
|
Aug 06, 2026 | BUY |
Strong Buy
+12.2% avg upside
10 analysts
|
$130.00
14.72% Upside
|
+14.7% | Β· |
|
XGN
Exagen
|
Aug 05, 2026 | BUY |
Strong Buy
+50.2% avg upside
11 analysts
|
$9.00
4.87% Upside
|
-37.9% | Β· |
|
SOPH
SOPHiA GENETICS
|
Aug 05, 2026 | BUY |
Strong Buy
+36.9% avg upside
8 analysts
|
$9.00
18.05% Upside
|
+30.3% | Β· |
|
WGS
GeneDx Holdings
|
Aug 04, 2026 | BUY |
Strong Buy
+22.6% avg upside
10 analysts
|
$90.00
30.25% Upside
|
-26.1% | Β· |
|
CSTL
Castle Biosciences
|
Aug 03, 2026 | BUY |
Strong Buy
+16.9% avg upside
10 analysts
|
$44.00
18.49% Upside
|
+11.2% | Β· |
|
ZTS
Zoetis
|
Feb 26, 2026 | BUY |
Buy
+43.7% avg upside
25 analysts
|
$160.00
100.79% Upside
|
-35.4% | Β· |
|
IDXX
Idexx Laboratories
|
Feb 03, 2026 | BUY |
Buy
+30.3% avg upside
19 analysts
|
$800.00
45.12% Upside
|
+9.5% | Β· |
|
BNGO
BioNano Genomics
|
Aug 22, 2025 | HOLD |
Buy
+722.6% avg upside
9 analysts
|
β | -70.0% | Β· |
|
RNLXY
Renalytix
|
May 20, 2024 | BUY |
Strong Buy
+190.7% avg upside
5 analysts
|
$2.00
45.99% Downside
|
Β· | Β· |
|
HLTHQ
Cue Health
|
Mar 21, 2024 | HOLD |
Hold
2 analysts
|
β | Β· | Β· |
|
TTOO
T2 Biosystems
|
Sep 22, 2023 | HOLD |
Buy
+1015078.6% avg upside
10 analysts
|
β | Β· | Β· |
|
HTGMQ
HTG Molecular Diagnostics
|
Dec 06, 2019 | HOLD |
Strong Buy
+733333233.4% avg upside
6 analysts
|
β | Β· | Β· |
|
QDEL
QuidelOrtho
|
Nov 17, 2019 | BUY |
Strong Buy
+195.9% avg upside
13 analysts
|
$75.00
466.09% Upside
|
+201.7% | Β· |
|
OSUR
Orasure Technologies
|
Nov 10, 2019 | HOLD |
Buy
+111.5% avg upside
12 analysts
|
$8.00
103.03% Upside
|
+54.8% | Β· |
|
QTRX
Quanterix
|
Nov 06, 2019 | BUY |
Buy
+548.5% avg upside
8 analysts
|
$35.00
1104.84% Upside
|
+157.7% | Β· |
|
LH
Labcorp Holdings
|
Oct 24, 2019 | HOLD |
Strong Buy
-21.6% avg upside
38 analysts
|
$170.00
52.91% Downside
|
+26.3% | Β· |
|
ILMN
Illumina
|
Oct 24, 2019 | HOLD |
Strong Buy
-10.1% avg upside
32 analysts
|
$310.00
31.31% Upside
|
+2.5% | Β· |
|
DGX
Quest Diagnostics
|
Oct 22, 2019 | BUY |
Buy
-26.4% avg upside
34 analysts
|
$113.00
55.14% Downside
|
+28.2% | Β· |
|
AWHL
Aspira Women's Health
|
May 23, 2018 | HOLD |
Buy
+2471.5% avg upside
6 analysts
|
$1.00
376.25% Upside
|
Β· | Β· |
|
RIOT
Riot Platforms
|
Feb 09, 2016 | HOLD |
Strong Buy
+124.9% avg upside
30 analysts
|
$4.00
68.83% Downside
|
Β· | Β· |
|
BDX
Becton Dickinson
|
May 07, 2015 | HOLD |
Buy
-0.4% avg upside
25 analysts
|
$145.00
26.78% Downside
|
+17.5% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.